Lilly to buy non-opioid pain biotech SiteOne for up to $1B
Eli Lilly is deepening its presence in the non-opioid pain field by buying California startup SiteOne Therapeutics, which is in a similar arena as the recent landmark approval for Vertex's pain drug. The Indianapolis drugmaker ...
Eli Lilly is deepening its presence in the non-opioid pain field by buying California startup SiteOne Therapeutics, which is in a similar arena as the recent landmark approval for Vertex's pain drug.
The Indianapolis drugmaker ...
